Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(8%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
10
83%
Ph phase_2
1
8%
Ph not_applicable
1
8%

Phase Distribution

10

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
10(83.3%)
Phase 2Efficacy & side effects
1(8.3%)
N/ANon-phased studies
1(8.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(3)
Completed(7)
Terminated(1)
Other(1)

Detailed Status

Completed7
Not yet recruiting2
Withdrawn1
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 110 (83.3%)
Phase 21 (8.3%)
N/A1 (8.3%)

Trials by Status

completed758%
withdrawn18%
active_not_recruiting18%
not_yet_recruiting217%
unknown18%

Recent Activity

1 active trials
Showing 5 of 12
not_yet_recruitingphase_1

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study

NCT07044765
not_yet_recruitingphase_1

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults

NCT07034781
completedphase_1

To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C711 in Healthy Adults

NCT06931327
active_not_recruitingphase_1

To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in Healthy Adults

NCT06933459
completednot_applicable

Bioequivalence Study of Rosuvastatin Tablet

NCT05637060
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT07044765Phase 1

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study

Not Yet Recruiting
NCT07034781Phase 1

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults

Not Yet Recruiting
NCT06931327Phase 1

To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C711 in Healthy Adults

Completed
NCT06933459Phase 1

To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in Healthy Adults

Active Not Recruiting
NCT05637060Not Applicable

Bioequivalence Study of Rosuvastatin Tablet

Completed
NCT03821480Phase 1

Diflucan Bioequivalence Study For Transferring The Manufacture

Completed
NCT04322032Phase 1

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-389

Unknown
NCT04075643Phase 1

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers

Completed
NCT04083872Phase 1

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)

Completed
NCT00000331Phase 2

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6

Withdrawn
NCT01638598Phase 1

Single Rising Oral Doses of BI 1021958 in Healthy Chinese and Japanese Male Volunteers

Completed
NCT01260805Phase 1

A Bioequivalence Study Of Ethinylestradiol + Gestodene In Female And Healthy Volunteers.

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12